Grace Cui
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Multiple Myeloma Research and Treatments 3
- Blood Coagulation and Thrombosis Mechanisms 2
- Co-authors
- Gregory M. Lanza (12 shared papers)Anne H. Schmieder (9 shared papers)Dipanjan Pan (7 shared papers)Xiaoxia Yang (6 shared papers)John S. Allen (7 shared papers)Angana Senpan (4 shared papers)Samuel A. Wickline (4 shared papers)Huiying Zhang (2 shared papers)
- Journals
- Theranostics (5 papers)Nanomedicine Nanotechnology Biology and Medicine (3 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)Renal Failure (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Grace Cui
15 papers receiving 278 citations
Peers
Comparison fields: 5 of 66
- Biomaterials 60
- Hematology 41
- Immunology and Allergy 13
- Cancer Research 31
- Immunology 42
Countries citing papers authored by Grace Cui
This map shows the geographic impact of Grace Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Cui more than expected).
Fields of papers citing papers by Grace Cui
This network shows the impact of papers produced by Grace Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Cui. The network helps show where Grace Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Grace Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 45 | |
| 2 | 2014 | 44 | |
| 3 | 2020 | 31 | |
| 4 | 2015 | 31 | |
| 5 | 2020 | 19 | |
| 6 | 2017 | 18 | |
| 7 | 1985 | 18 | |
| 8 | 2016 | 15 | |
| 9 | 2015 | 13 | |
| 10 | 2018 | 10 | |
| 11 | 2015 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2015 | 8 | |
| 15 | 2025 | 2 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 |
About Grace Cui
Grace Cui is a scholar working on Molecular Biology, Hematology, Oncology, Radiology, Nuclear Medicine and Imaging and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 281 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Multiple Myeloma Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Nanoplatforms for cancer theranostics (2 papers), Cell Adhesion Molecules Research (2 papers), MRI in cancer diagnosis (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). The work is most often cited by research in Biomaterials (60 citations), Hematology (41 citations), Immunology and Allergy (13 citations), Cancer Research (31 citations) and Immunology (42 citations). Grace Cui has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Gregory M. Lanza, Anne H. Schmieder, Dipanjan Pan, Xiaoxia Yang, John S. Allen, Angana Senpan, Samuel A. Wickline, Huiying Zhang, Katherine N. Weilbaecher and Long Shen. Their work appears in journals such as Theranostics, Nanomedicine Nanotechnology Biology and Medicine, Molecular Cancer Therapeutics, Clinical Cancer Research and Renal Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.